Delamanid

64 interactions 4 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Amitriptyline Gatifloxacin Ophthalmic Buprenorphine Relugolix Ketoconazole Topical Foscarnet Injection

62 Major 2 Moderate

All (64) Major (62) Moderate (2)

Major

Delamanid Amitriptyline Elavil Explained Increased risk of QT-interval prolongation Details Delamanid Sertraline Explained An increased risk of QT interval prolongation Details Delamanid Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Delamanid Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Delamanid Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Delamanid Arsenic Trioxide Trisenox Increased risk of QT interval prolongation Details Delamanid Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Delamanid Arsenic Trioxide Injection Trisenox Increased risk of QT interval prolongation Details Delamanid Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Delamanid Azithromycin AzaSite Increased risk of QT interval prolongation Details Delamanid Alfuzosin UroXatral Increased risk of QT interval prolongation Details Delamanid Anagrelide Agrylin Increased risk of QT interval prolongation Details Delamanid Bedaquiline Sirturo Increased risk of QT interval prolongation Details Delamanid Chloroquine Aralen® Increased risk of QT interval prolongation Details Delamanid Dasatinib Phyrago Increased risk of QT interval prolongation Details Delamanid Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Delamanid Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Delamanid Disopyramide Norpace Increased risk of QT interval prolongation Details Delamanid Dofetilide Tikosyn Increased risk of QT interval prolongation Details Delamanid Dolasetron Anzemet Increased risk of QT interval prolongation Details Delamanid Dolasetron Injection Anzemet Increased risk of QT interval prolongation Details Delamanid Encorafenib Braftovi Increased risk of QT interval prolongation Details Delamanid Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Delamanid Eribulin Injection Halaven Increased risk of QT interval prolongation Details Delamanid Famotidine Calmicid Increased risk of QT interval prolongation Details Delamanid Famotidine Injection Calmicid Increased risk of QT interval prolongation Details Delamanid Felbamate Felbatol Increased risk of QT interval prolongation Details Delamanid Flecainide Tambocor® Increased risk of QT interval prolongation Details Delamanid Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Delamanid Fostemsavir Rukobia Increased risk of torsade de pointes Details Delamanid Galantamine Razadyne Increased risk of QT interval prolongation Details Delamanid Gatifloxacin Ophthalmic Zymar® Increased risk of QT interval prolongation Details Delamanid Gemifloxacin Factive Increased risk of QT interval prolongation Details Delamanid Glasdegib Daurismo Increased risk of QT interval prolongation Details Delamanid Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Delamanid Granisetron Transdermal Patch Sancuso Increased risk of QT interval prolongation Details Delamanid Granisetron Injection Granisol Increased risk of QT interval prolongation Details Delamanid Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Delamanid Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Delamanid Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.